fda glp 1 shortage list Cracks Down on Compounded GLP-1 Drugs | Paul Healy 💊🧬 posted on the topic GLP-1 No Longer on FDA's

& Dawson, A

Lilly also committed an additional US$4.5 billion across Indiana manufacturing sites, with the company stating that planned production includes Foundayo, Zepbound, Mounjaro and retatrutide-related capacity, highlighting how manufacturing scale has become central to GLP-1 market leadership

Those are all things that when you hear that, you need to be thinking, Wow, have I asked this person about mold exposure? Or, Maybe I need to do that biotoxin survey and have them do the visual contrast sensitivity test. Those are big flags

These injections are particularly benecial for those looking to boost their immune system, enhance skin health, and support overall detoxication processes

GLP-1 drugs have had a pretty wild rise

Mounjaro, the diabetes-labeled version of tirzepatide, comes in around $1,080 for the same period